Search research articles
Contact Us
Filters
Showing results (61-70 of 70) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 70 results.
British Journal of Cancer
|
September 27, 2007
A prospective randomised phase III trial of adjuvant chemotherapy with 5-fluorouracil and leucovorin in patients with stage II colon cancer
W Schippinger, H Samonigg, R Schaberl-Moser, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 24, 2012
Phase IB study of the EpCAM antibody adecatumumab combined with docetaxel in patients with EpCAM-positive relapsed or refractory advanced-stage breast cancer
M Schmidt, D Rüttinger, M Sebastian, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 1, 2005
Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial
M Karthaus, A Kretzschmar, H Kröning, et al.
Cancer Chemotherapy and Pharmacology
|
February 28, 2001
Docetaxel monotherapy in heavily pretreated metastatic breast cancer: a multicenter, community-based feasibility trial
M Schmidinger, A C Budinsky, C Wenzel, et al.
British Journal of Cancer
|
January 12, 2012
Brain metastases free survival differs between breast cancer subtypes
A Berghoff, Z Bago-Horvath, C De Vries, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 21, 2016
Final efficacy and updated safety results of the randomized phase III BEATRICE trial evaluating adjuvant bevacizumab-containing therapy in triple-negative early breast cancer
R Bell, J Brown, M Parmar, et al.
British Journal of Cancer
|
March 21, 2013
Efficacy of tamoxifen ± aminoglutethimide in normal weight and overweight postmenopausal patients with hormone receptor-positive breast cancer: an analysis of 1509 patients of the ABCSG-06 trial
G Pfeiler, H Stöger, P Dubsky, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 19, 2013
Epirubicin and docetaxel with or without capecitabine as neoadjuvant treatment for early breast cancer: final results of a randomized phase III study (ABCSG-24)
G G Steger, R Greil, A Lang, et al.
Breast Cancer Research : BCR
|
January 24, 2025
Outcomes in stage IIA versus stage IIB/III in the PALLAS trial [ABCSG-42/AFT-05/PrE0109/BIG-14-13])
A DeMichele, A C Dueck, D Hlauschek, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 17, 2021
Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study
N Harbeck, P Rastogi, M Martin, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 70) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 70 results.
British Journal of Cancer
|
September 27, 2007
A prospective randomised phase III trial of adjuvant chemotherapy with 5-fluorouracil and leucovorin in patients with stage II colon cancer
W Schippinger, H Samonigg, R Schaberl-Moser, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 24, 2012
Phase IB study of the EpCAM antibody adecatumumab combined with docetaxel in patients with EpCAM-positive relapsed or refractory advanced-stage breast cancer
M Schmidt, D Rüttinger, M Sebastian, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 1, 2005
Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial
M Karthaus, A Kretzschmar, H Kröning, et al.
Cancer Chemotherapy and Pharmacology
|
February 28, 2001
Docetaxel monotherapy in heavily pretreated metastatic breast cancer: a multicenter, community-based feasibility trial
M Schmidinger, A C Budinsky, C Wenzel, et al.
British Journal of Cancer
|
January 12, 2012
Brain metastases free survival differs between breast cancer subtypes
A Berghoff, Z Bago-Horvath, C De Vries, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 21, 2016
Final efficacy and updated safety results of the randomized phase III BEATRICE trial evaluating adjuvant bevacizumab-containing therapy in triple-negative early breast cancer
R Bell, J Brown, M Parmar, et al.
British Journal of Cancer
|
March 21, 2013
Efficacy of tamoxifen ± aminoglutethimide in normal weight and overweight postmenopausal patients with hormone receptor-positive breast cancer: an analysis of 1509 patients of the ABCSG-06 trial
G Pfeiler, H Stöger, P Dubsky, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 19, 2013
Epirubicin and docetaxel with or without capecitabine as neoadjuvant treatment for early breast cancer: final results of a randomized phase III study (ABCSG-24)
G G Steger, R Greil, A Lang, et al.
Breast Cancer Research : BCR
|
January 24, 2025
Outcomes in stage IIA versus stage IIB/III in the PALLAS trial [ABCSG-42/AFT-05/PrE0109/BIG-14-13])
A DeMichele, A C Dueck, D Hlauschek, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 17, 2021
Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study
N Harbeck, P Rastogi, M Martin, et al.
Page
of 7